Search research articles
Contact Us
Filters
Showing results (121-130 of 159) with videos related to
Page
of 16
Sort By:
NPJ Breast Cancer
|
July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
JAMA Oncology
|
March 9, 2023
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial
Tufia C Haddad, Vera J Suman, Antonino B D'Assoro, et al.
Journal of Hepatology
|
November 12, 2024
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
Changhoon Yoo, Hyehyun Jeong, Jae Ho Jeong, et al.
Cell Reports. Medicine
|
November 7, 2024
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
Michael J Campbell, Denise M Wolf, Christina Yau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657
Laura J Esserman, Donald A Berry, Angela DeMichele, et al.
JAMA Oncology
|
July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
The Oncologist
|
July 18, 2024
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, et al.
Nature Communications
|
April 18, 2023
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
Jodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2017
First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer
Matthew P Goetz, Vera J Suman, Joel M Reid, et al.
Cancer Immunology Research
|
December 16, 2021
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
Ti Wen, Whitney Barham, Ying Li, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 159) with videos related to
Sort By:
Page
of 16
NPJ Breast Cancer
|
July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
JAMA Oncology
|
March 9, 2023
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial
Tufia C Haddad, Vera J Suman, Antonino B D'Assoro, et al.
Journal of Hepatology
|
November 12, 2024
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
Changhoon Yoo, Hyehyun Jeong, Jae Ho Jeong, et al.
Cell Reports. Medicine
|
November 7, 2024
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
Michael J Campbell, Denise M Wolf, Christina Yau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657
Laura J Esserman, Donald A Berry, Angela DeMichele, et al.
JAMA Oncology
|
July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
The Oncologist
|
July 18, 2024
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, et al.
Nature Communications
|
April 18, 2023
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
Jodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2017
First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer
Matthew P Goetz, Vera J Suman, Joel M Reid, et al.
Cancer Immunology Research
|
December 16, 2021
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
Ti Wen, Whitney Barham, Ying Li, et al.
Page
of 16